Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of Northwest Nigeria

Journal of Infectious Diseases

Volumn 210, Issue , 2014, Pages S412-S423

  Kalkowska, Dominika A ^a,b   Tebbens, Radboud J Duintjer ^a   Thompson, Kimberly M ^a  

^a Kid Risk Inc   (United States)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

eradication; IPV; OPV; polio; population immunity

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; HIGH RISK POPULATION; IMMUNITY; INFECTION PREVENTION; NIGERIA; POLIOMYELITIS; POLIOMYELITIS VIRUS; POPULATION MODEL; RISK REDUCTION; STRATEGIC PLANNING; VACCINATION; VACCINE DERIVED POLIOVIRUS TYPE 2; VIRUS TRANSMISSION; WILD POLIOVIRUS TYPE 1; ADOLESCENT; ADULT; AGED; CHILD; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PROCEDURES; STATISTICAL MODEL; TRANSMISSION; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, STATISTICAL; NIGERIA; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; VACCINATION; YOUNG ADULT;

EID: 84893793600     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit834     Document Type: Article

References (17)

1. Thompson KM, Pallansch MA, Duintjer Tebbens RJ, Was silak SG, Kim J-H, Cochi SL. Pre-eradication vaccine policy options for poliovirus infection and disease control. Risk Anal 2013; 33:516-43.
2. Centers for Disease Control and Prevention. Progress toward poliomyelitis eradication-Nigeria, 1996- 1998. MMWR 1999; 48:312-6.
3. World Health Organization. Transmission of wild poliovirus type 2: apparent global interruption. Wkly Epidemiol Rec 2001; 76:95-7.
4. Centers for Disease Control and Prevention. Resurgence of wild poliovirus type 1 transmission and consequences of importation-21 previously polio-free countries, 2002-2005. MMWR 2006; 55:145-50.
5. Thompson KM, Duintjer Tebbens RJ. Current polio global eradication and control policy options: perspectives from modeling and prerequisites for OPV cessation. Ex pert Rev Vaccines 2012; 11:449-59.
6. Duintjer Tebbens RJ, Pallansch MA, Kalkowska DA, Wassilak SG, Cochi SL, Thompson KM. Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccinerelated polioviruses. Risk Anal 2013; 23:703-49.
7. Duintjer Tebbens RJ, Kalkowska DA, Wassilak SGF, Pallansch MA, Cochi SL, Thompson KM. The po tential impact of expanding target age groups for polio immunization campaigns. BMC Infect Dis 2014; 14: 45.
8. Duintjer Tebbens RJ, Pallansch MA, Kim J-H, et al. Oral poliovirus vaccine evoluti on and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs). Risk Anal 2013; 23: 680-702.
9. Wassilak SGF, Pate MA, Wannemuehler K, et al. Outbreak of typ e 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis 2011; 203:898-909.
10. World Health Assembly. Poliomyelitis: Intensification of the global eradication initiative (resolution 66.18). Geneva:World Health Organization, 2013.
11. World Health Organization. Globa l Polio Eradication Initiative: list of wild poliovirus by country. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek/Wildpolioviruslist.aspx. Accessed 24 September 2013.
12. Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India J Infect Dis 2014; 210(suppl 1):S398-411.
13. Nigeria/Africa Mas terweb. Nigeria 2006 Census Figures. http://www.nigeriamasterweb.com/Nigeria06CensusFigs.html. Accessed 11 February 2013.
14. Estivariz CF, Pallansch MA, Anand A, et al. Poliovirus vaccination options for achieving eradication and securing the endgame. Curr Opin Virol 2013; 3:309-15.
15. Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, et al. Expert review on poliovirus immunity and transmission. Risk Anal 2013; 33: 544-605.
16. Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, et al. Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identificatio n of research needs. Risk Anal 2013; 33:606-46.
17. Anis E, Kopel E, Singer S, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveillance 2013; 18: pii=20586.